{
    "Rank": 421,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT01292733",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "IR 4707"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "CRC 08108",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "Swedish Medical Center"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Swedish Medical Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer",
                "OfficialTitle": "Ovarian Cancer Early Detection Screening Program",
                "Acronym": "OCEDP"
            },
            "StatusModule": {
                "StatusVerifiedDate": "January 2016",
                "OverallStatus": "Terminated",
                "WhyStopped": "Closed per local IRB due to advancements in standard ovarian cancer screening.",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "August 2009"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "December 2015",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "December 2015",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "November 30, 2010",
                "StudyFirstSubmitQCDate": "February 8, 2011",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "February 9, 2011",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "January 15, 2016",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "January 20, 2016",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Swedish Medical Center",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "Fred Hutchinson Cancer Center",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "The Marsha Rivkin Center for Ovarian Cancer Research",
                            "CollaboratorClass": "OTHER"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "The main purpose of this program is to see whether periodically measuring CA-125 (tumor marker) levels in the blood and undergoing transvaginal ultrasounds over time will be effective in the early detection of ovarian cancer.",
                "DetailedDescription": "The program will offer twice yearly CA-125 blood tests and annual transvaginal ultrasounds to monitor women at high risk for ovarian cancer. In addition to the main purpose of providing ovarian cancer screening, the researchers would also like to build a repository of blood specimens for use in ovarian and breast cancer research and to offer genetics counseling sessions to help educate women about risk-reducing options."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Ovarian Diseases",
                        "Ovarian Neoplasms"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Women with increased risk for developing ovarian cancer",
                        "Women diagnosed with reproductive cancer",
                        "Women with relatives who have had ovarian or breast cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Early Phase 1"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "N/A",
                    "DesignInterventionModel": "Single Group Assignment",
                    "DesignPrimaryPurpose": "Prevention",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "534",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Ovarian Cancer Screening",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "CA125 tumor marker, Transvaginal Ultrasound, Health Status Questionnaires",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: Laboratory Tumor Marker Analysis",
                                    "Other: Transvaginal Ultrasound",
                                    "Other: Health Status Questionnaire"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Laboratory Tumor Marker Analysis",
                            "InterventionDescription": "Performed every 6 months, these blood samples will be drawn to measure the concentration of CA125 tumor marker. Remaining samples will be stored in a specimen repository for use in future research for ovarian and breast cancer tumor markers.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Ovarian Cancer Screening"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Transvaginal Ultrasound",
                            "InterventionDescription": "Performed annually, these pelvic ultrasounds will be used used to look for 1) enlargement of one or both ovaries or 2) suspicious or indeterminate morphometric parameters, determined by the presence of intracystic papillations, and/or mural nodularity.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Ovarian Cancer Screening"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Health Status Questionnaire",
                            "InterventionDescription": "Performed every 6 months, these questionnaires will ask about your health and medical history, environmental exposures, and family history.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Ovarian Cancer Screening"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Measuring for elevated levels of tumor marker CA-125 in the blood over time.",
                            "PrimaryOutcomeTimeFrame": "Average expected time of 1 year"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Performing transvaginal ultrasounds to look for any abnormalities over time.",
                            "SecondaryOutcomeDescription": "Criteria for an abnormal scan include 1) enlargement of one or both ovaries or 2) suspicious or indeterminate morphometric parameters, determined by the presence of intracystic papillations, and/or mural nodularity. Volume calculations will determine whether the ovary is enlarged.",
                            "SecondaryOutcomeTimeFrame": "Average expected time of 1 year"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Performing health status questionnaires over time",
                            "SecondaryOutcomeTimeFrame": "Average expected time of 1 year"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nMust meet one of the following:\n\nThe family contains at least two ovarian or breast cancers in the subject or first or second degree relatives of the subject.\nThe subject is of Ashkenazi Jewish ethnicity with one first degree or two second-degree relatives with breast or ovarian cancer, or subject is of Ashkenazi ancestry and has had breast cancer.\nThe subject has a male relative with breast cancer diagnosed at any age.\nProbability of carrying a BRCA1/2 mutation given family pedigree of breast and ovarian cancers exceeds 20% (as determined by BRCAPRO 95% posterior probability interval).\n\nExclusion Criteria:\n\nPrior ovarian cancer or peritoneal carcinomatosis\nA first or second degree relative with a BRCA1/2 mutation and has tested negative for exactly the same mutation.\nThe subject has no ovaries.\nLess than 30 years of age, unless 25-30 with BRCA I or II mutation confirmed\nCurrently pregnant\nCurrently receiving adjuvant chemotherapy or radiation therapy for cancer (excluding tamoxifen). Patients who are being treated for local disease may enroll 3 months after completion of last treatment (excluding tamoxifen).\nTreatment (excluding tamoxifen) for prior metastatic malignancy within the past five years.\nIntraperitoneal surgery within the last 3 months.",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "Female",
                "MinimumAge": "30 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Pamela Paley, MD",
                            "OverallOfficialAffiliation": "Swedish Medical Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Marsha Rivkin Center for Ovarian Cancer Research",
                            "LocationCity": "Seattle",
                            "LocationState": "Washington",
                            "LocationZip": "98122",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "SeeAlsoLinkList": {
                    "SeeAlsoLink": [
                        {
                            "SeeAlsoLinkLabel": "Marsha Rivkin Center for Ovarian Cancer Research",
                            "SeeAlsoLinkURL": "http://www.marsharivkin.org/research/screening.html"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000010051",
                            "ConditionMeshTerm": "Ovarian Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000077216",
                            "ConditionMeshTerm": "Carcinoma, Ovarian Epithelial"
                        },
                        {
                            "ConditionMeshId": "D000010049",
                            "ConditionMeshTerm": "Ovarian Diseases"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000004701",
                            "ConditionAncestorTerm": "Endocrine Gland Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000000291",
                            "ConditionAncestorTerm": "Adnexal Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005831",
                            "ConditionAncestorTerm": "Genital Diseases, Female"
                        },
                        {
                            "ConditionAncestorId": "D000052776",
                            "ConditionAncestorTerm": "Female Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005261",
                            "ConditionAncestorTerm": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005833",
                            "ConditionAncestorTerm": "Genital Neoplasms, Female"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000004700",
                            "ConditionAncestorTerm": "Endocrine System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000006058",
                            "ConditionAncestorTerm": "Gonadal Disorders"
                        },
                        {
                            "ConditionAncestorId": "D000002277",
                            "ConditionAncestorTerm": "Carcinoma"
                        },
                        {
                            "ConditionAncestorId": "D000009375",
                            "ConditionAncestorTerm": "Neoplasms, Glandular and Epithelial"
                        },
                        {
                            "ConditionAncestorId": "D000009370",
                            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M12664",
                            "ConditionBrowseLeafName": "Ovarian Neoplasms",
                            "ConditionBrowseLeafAsFound": "Ovarian Neoplasms",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M1704",
                            "ConditionBrowseLeafName": "Carcinoma, Ovarian Epithelial",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12662",
                            "ConditionBrowseLeafName": "Ovarian Diseases",
                            "ConditionBrowseLeafAsFound": "Ovarian Diseases",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M5224",
                            "ConditionBrowseLeafName": "Carcinoma",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M7553",
                            "ConditionBrowseLeafName": "Endocrine Gland Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M3333",
                            "ConditionBrowseLeafName": "Adnexal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8633",
                            "ConditionBrowseLeafName": "Genital Diseases, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26783",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13817",
                            "ConditionBrowseLeafName": "Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8089",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases and Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8635",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M7552",
                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8853",
                            "ConditionBrowseLeafName": "Gonadal Disorders",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12010",
                            "ConditionBrowseLeafName": "Neoplasms, Glandular and Epithelial",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12005",
                            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T4352",
                            "ConditionBrowseLeafName": "Ovarian Cancer",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "T4354",
                            "ConditionBrowseLeafName": "Ovarian Epithelial Cancer",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC19",
                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "Rare",
                            "ConditionBrowseBranchName": "Rare Diseases"
                        }
                    ]
                }
            }
        }
    }
}